Action THER THERALINK TECHNOLOGIES, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Theralink Technologies, Inc.

Actions

THER

US88339Q1094

Marché Fermé - OTC Markets
Autres places de cotation
 20:15:16 01/07/2024 		Varia. 5j. Varia. 1 janv.
0,0001 USD 0,00 % Graphique intraday de Theralink Technologies, Inc. 0,00 % -93,33 %
07/05 IMAC Holdings, Inc. (NasdaqCM:BACK) a acquis les actifs de Theralink Technologies, Inc. CI
06/05 Theralink Technologies, Inc. (OTCPK:THER) a annulé l'acquisition d'IMAC Holdings, Inc. (NasdaqCM:BACK) dans le cadre d'une opération de fusion inversée. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
IMAC Holdings, Inc. acquired Assets of Theralink Technologies, Inc.
Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction.
Theralink Technologies : Accelaration/Increase of Financial Obligation - Form 8-K
Theralink Technologies, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023
Theralink Technologies, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023
Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates
Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4
Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board
Theralink Technologies, Inc. Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute?s Molecular Tumor Board
Four Penny Stocks That Might Move On News (EPAZ, THER, SDNR, HNRC)
Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023
Theralink Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023
IMAC Holdings, Inc. announced that it has received $4.3 million in funding from Theralink Technologies, Inc. and other investors
Theralink Technologies, Inc. Announces Chief Executive Officer Changes
Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer
Theralink Technologies, Inc. Appoints Mick Ruxin as Chief Medical Officer
Theralink Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
Theralink Technologies, Inc. entered into a definitive agreement and plan of merger to acquire IMAC Holdings, Inc. for $0.9 million in a reverse merger transaction.
Theralink Technologies, Inc. Announces Termination of Thomas Chilcott as Treasurer and Secretary
Theralink Technologies, Inc. Announces CFO Changes
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action THER
  4. Actualités Theralink Technologies, Inc.
  5. Autres langues